Business Description

Metagenomi Inc
NAICS : 541713 SIC : 2834
ISIN : US59102M1045
Compare
Compare
Traded in other countries / regions
MGX.USA
IPO Date
2024-02-09
Description
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).
Name Current Vs Industry Vs History
Cash-To-Debt 5.62
Equity-to-Asset -0.37
Debt-to-Equity -0.36
Debt-to-EBITDA -1.47
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.07
Distress
Grey
Safe
Beneish M-Score -1.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 40.79
9-Day RSI 38.39
14-Day RSI 37.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.04
Quick Ratio 4.04
Cash Ratio 3.94
Days Sales Outstanding 42.76

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
Operating Margin % -172
Net Margin % -157.96
FCF Margin % -408.78
ROA % -9.94
ROIC % -36.88
ROC (Joel Greenblatt) % -61.06
ROCE % -10.63

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 9.94
EV-to-EBIT -0.64
EV-to-EBITDA -0.69
EV-to-Revenue 0.91
EV-to-Forward-Revenue 0.69
EV-to-FCF -0.22
Earnings Yield (Greenblatt) % -156.25
FCF Yield % -41.24

Financials

MGX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MGX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Metagenomi Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 24.762
EPS (TTM) ($) -1.042
Beta 0
Volatility % 0
14-Day RSI 37.04
14-Day ATR ($) 0.737104
20-Day SMA ($) 7.1125
12-1 Month Momentum % 0
52-Week Range ($) 5.5 - 12.74
Shares Outstanding (Mil) 37.47

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Metagenomi Inc Filings

Filing Date Document Date Form
No Filing Data

Metagenomi Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Metagenomi Inc Frequently Asked Questions

What is Metagenomi Inc(MGX)'s stock price today?
The current price of MGX is $6.55. The 52 week high of MGX is $12.74 and 52 week low is $5.50.
When is next earnings date of Metagenomi Inc(MGX)?
The next earnings date of Metagenomi Inc(MGX) is .
Does Metagenomi Inc(MGX) pay dividends? If so, how much?
Metagenomi Inc(MGX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1